Literature DB >> 2425452

Association between HLA-D region epitopes and multiple sclerosis in Arabs.

A S Al-Din, M Al-Saffar, R Siboo, K Behbehani.   

Abstract

We have studied the HLA associations of MS patients in Arab patients from two regions. Those patients from the Mediterranean area showed an association of MS with HLA-DR2 (p less than 0.001) and -DQw1 (p less than 0.05), whilst in those from the Gulf there was an association with -DRw53 (p less than 0.02). In the Mediterranean patients -DRw52 was negatively associated with MS (p less than 0.05). In the control populations from the two regions there was a considerable variation in the incidence of HLA antigens. Thus, Gulf Arabs had an increased incidence of -DR1 (p less than 0.05), -DR2 (p less than 0.02), -DR6 (p less than 0.05) and decreased incidence of -DR5 (p less than 0.05), -DRw52 (p less than 0.02) and -DQw3 (p less than 0.01) compared to the Mediterranean control population. These findings are discussed in relation to the aetiology of the disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2425452     DOI: 10.1111/j.1399-0039.1986.tb01520.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  8 in total

Review 1.  HLA and multiple sclerosis in Italy: a review of the literature.

Authors:  L La Mantia; M T Illeni; C Milanese; A Salmaggi; M Eoli; G Pellegris; A Nespolo
Journal:  J Neurol       Date:  1990-11       Impact factor: 4.849

2.  Population frequency of HLA haplotypes contributes to the prevalence difference of multiple sclerosis in Ireland.

Authors:  Christopher McGuigan; Ciaran Dunne; John Crowley; Richard Hagan; Genevieve Rooney; Eimear Lawlor; Michael Hutchinson
Journal:  J Neurol       Date:  2005-09-16       Impact factor: 4.849

3.  HLA-DR and tuberculin tests in rheumatoid arthritis and tuberculosis.

Authors:  G M Bahr; M A Sattar; J L Stanford; M A Shaaban; B Al Shimali; Z Siddiqui; M Gabriel; M Al Saffar; A Shahin; T D Chugh
Journal:  Ann Rheum Dis       Date:  1989-01       Impact factor: 19.103

4.  Class II HLA antigens in multiple sclerosis.

Authors:  D H Miller; R W Hornabrook; J Dagger; R Fong
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-05       Impact factor: 10.154

5.  HLA and multiple sclerosis in south east Wales.

Authors:  R J Swingler; P F Kirk; C Darke; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-09       Impact factor: 10.154

6.  Antibody levels to mycobacteria in relation to HLA type: evidence for non-HLA-linked high levels of antibody to the 65 kD heat shock protein of M. bovis in rheumatoid arthritis.

Authors:  G M Bahr; G A Rook; M al-Saffar; J Van Embden; J L Stanford; K Behbehani
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

7.  HLA-DR-associated isotype-specific regulation of antibody levels to mycobacteria in rheumatoid arthritis.

Authors:  G M Bahr; G A Rook; A Shahin; J L Stanford; M I Sattar; K Behbehani
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

Review 8.  The pathogenesis of multiple sclerosis. The Bradshaw lecture 1986.

Authors:  W I McDonald
Journal:  J R Coll Physicians Lond       Date:  1987-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.